Inventor
MANDAL JAYANTA KUMAR
IN30 patents
⚠️ This page may combine multiple inventors who share the name “MANDAL JAYANTA KUMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIQMEDS WORLDWIDE LTD
22 patentsUS11337979B2May 24, 2022
Liquid oral formulations for sildenafil
LIQMEDS WORLDWIDE LTD3 citations82
US11253474B1Feb 22, 2022
Pharmaceutical solution of amlodipine
LIQMEDS WORLDWIDE LTD4 citations82
US12005141B2Jun 11, 2024
Pharmaceutical solution of amlodipine
LIQMEDS WORLDWIDE LTD1 citations71
US11723866B2Aug 15, 2023
Pharmaceutical solution of amlodipine
LIQMEDS WORLDWIDE LTD1 citations71
US11464778B2Oct 11, 2022
Liquid oral formulations for sildenafil
LIQMEDS WORLDWIDE LTD2 citations71
US11458095B2Oct 4, 2022
Pharmaceutical solution of amlodipine
LIQMEDS WORLDWIDE LTD1 citations71
US11918684B2Mar 5, 2024
Pharmaceutical composition of oral suspension of immunosuppressive agents
LIQMEDS WORLDWIDE LTD2 citations70
US12186322B2Jan 7, 2025
Liquid oral formulations for tadalafil
LIQMEDS WORLDWIDE LTD0 citations61
US12186321B2Jan 7, 2025
Liquid oral formulations for sildenafil
LIQMEDS WORLDWIDE LTD0 citations61
US12005062B2Jun 11, 2024
Liquid oral formulations for sildenafil
LIQMEDS WORLDWIDE LTD0 citations61
US11975006B2May 7, 2024
Liquid oral formulations for tadalafil
LIQMEDS WORLDWIDE LTD0 citations61
US11759468B2Sep 19, 2023
Liquid oral formulations for sildenafil
LIQMEDS WORLDWIDE LTD0 citations61
US11666576B2Jun 6, 2023
Liquid oral formulations for tadalafil
LIQMEDS WORLDWIDE LTD0 citations61
US11382917B2Jul 12, 2022
Liquid oral formulations for tadalafil
LIQMEDS WORLDWIDE LTD0 citations61
US12440441B2Oct 14, 2025
Pharmaceutical solution of amlodipine
LIQMEDS WORLDWIDE LTD0 citations60
US12370136B2Jul 29, 2025
Aqueous suspension suitable for oral administration
LIQMEDS WORLDWIDE LTD0 citations60
US12251361B2Mar 18, 2025
Solutions for oral dosage
LIQMEDS WORLDWIDE LTD0 citations60
US12226528B2Feb 18, 2025
Pharmaceutical solution of amlodipine
LIQMEDS WORLDWIDE LTD0 citations60
US12168069B2Dec 17, 2024
Aqueous suspension suitable for oral administration
LIQMEDS WORLDWIDE LTD0 citations60
US11925704B2Mar 12, 2024
Aqueous suspension suitable for oral administration
LIQMEDS WORLDWIDE LTD0 citations60
US11654106B2May 23, 2023
Aqueous suspension suitable for oral administration
LIQMEDS WORLDWIDE LTD0 citations60
US11369567B2Jun 28, 2022
Aqueous suspension suitable for oral administration
LIQMEDS WORLDWIDE LTD0 citations60
AZURITY PHARMACEUTICALS INC
3 patentsUS11529333B2Dec 20, 2022
Oral pharmaceutical composition comprising zonisamide and process of preparation thereof
AZURITY PHARMACEUTICALS INC1 citations70
US11478456B2Oct 25, 2022
Oral pharmaceutical composition comprising Zonisamide and process of preparation thereof
AZURITY PHARMACEUTICALS INC1 citations70
US12491179B2Dec 9, 2025
Oral pharmaceutical composition comprising zonisamide and process of preparation thereof
AZURITY PHARMACEUTICALS INC0 citations59
FTF PHARMA PRIVATE LTD
3 patentsUS11147810B2Oct 19, 2021
Pharmaceutical composition of oral suspension of anti-neoplastic alkylating agents
FTF PHARMA PRIVATE LTD6 citations69
US10314880B2Jun 11, 2019
Composition comprising bortezomib
FTF PHARMA PRIVATE LTD5 citations63
US11147817B2Oct 19, 2021
Pharmaceutical composition of pemetrexed
FTF PHARMA PRIVATE LTD0 citations57